Drug name - Exforge Hct
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8101599 | NOVARTIS | Pharmaceutical composition containing anti-hypertensive agents |
May, 2023
(7 months from now) | |
| US8475839 | NOVARTIS | Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
May, 2023
(7 months from now) | |
|
US8475839
(Pediatric) | NOVARTIS | Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
Nov, 2023
(1 year, 1 month from now) | |
Drugs and Companies using AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN ingredient
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 5MG BASE;12.5MG;160MG | TABLET;ORAL | Prescription |
| EQ 5MG BASE;25MG;160MG | TABLET;ORAL | Prescription |
| EQ 10MG BASE;12.5MG;160MG | TABLET;ORAL | Prescription |
| EQ 10MG BASE;25MG;160MG | TABLET;ORAL | Prescription |
| EQ 10MG BASE;25MG;320MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.